Atorvastatin Calcium is an HMG-CoA reductase inhibitor that lowers LDL cholesterol by blocking hepatic cholesterol biosynthesis, remaining one of the highest-volume cardiovascular generics worldwide. Simson Pharma's Atorvastatin Calcium reference standard and impurities support the rigorous stability-indicating testing this statin demands.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Atorvastatin Calcium Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.